Finance

Lists
Why is RICH up 2.93%?
Dive Deeper
RICH:BCBA
Laboratorios Richmond SACIF
ARS 1,405.00
+2.93%
(+40.00) 1D
Nov 13, 5:03:42 PM GMT-3  ·   ARS
All symbols
SymbolPriceChange% Change
Generating top insights for RICH...
Open
ARS 1,405.00
High
ARS 1,410.00
Low
ARS 1,370.00
Mkt. cap
19.90B
Avg. vol.
0.00
Volume
9.06K
Dividend
1.18%
Quarterly dividend
ARS 4.13
Ex-dividend date
Jun 12, 2026
P/E ratio
3.78
52-wk high
ARS 2,300.00
52-wk low
ARS 1,250.00
EPS
ARS 371.58
Shares outstanding
14.17M
No. of employees
620
Open
ARS 1,405.00
High
ARS 1,410.00
Low
ARS 1,370.00
Mkt. cap
19.90B
Avg. vol.
0.00
Volume
9.06K
Dividend
1.18%
Quarterly dividend
ARS 4.13
Ex-dividend date
Jun 12, 2026
P/E ratio
3.78
52-wk high
ARS 2,300.00
52-wk low
ARS 1,250.00
EPS
ARS 371.58
Shares outstanding
14.17M
No. of employees
620
News stories
From web sources and news partners
About Laboratorios Richmond SACIF
CEO-
Employees620
FoundedMay 1, 1935
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in ARS
Loading Previous Earnings...
Revenue
Net income
All values in ARS
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
30.69B
32.80B
50.19B
Cost of goods sold
-
13.81B
11.97B
17.99B
Cost of revenue
-
13.81B
11.97B
17.99B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
13.11B
14.74B
15.91B
Operating expense
-
16.71B
19.87B
21.26B
Total operating expenses
-
30.53B
31.85B
39.26B
Operating income
-
161.44M
951.60M
10.94B
Other non operating income
-
27.71B
-752.76M
2.96B
EBT including unusual items
-
25.16B
-8.38B
9.40B
EBT excluding unusual items
-
25.16B
-8.58B
6.63B
Income tax expense
-
2.51B
-866.74M
752.50M
Effective tax rate
-
9.97%
10.35%
8.01%
Other operating expenses
-
3.60B
5.13B
5.36B
Net income
-
22.59B
-8.65B
8.62B
Net profit margin
-
73.61%
-26.38%
17.18%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-5.32B
-5.42B
-5.83B
Net interest expenses
-
-5.32B
-5.42B
-5.83B
Depreciation and amortization charges
-
-
-
-
EBITDA
-
1.36B
3.61B
20.68B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps